跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML
Approved
STANDARD
MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
fe4d1fff692b1b4e
Company
Unknown
Type
Standard
Approval Details
Approval Id
fe4d1fff692b1b4e
Drug Name
MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML
Active Ingredients
Potassium Clavulanate diluted with Silica, colloidal hydrated (1:1) eqv. clavulanic acid
57mg/5ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
fe4d1fff692b1b4e
Type
Standard
Back to HSA Approvals
MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML - HSA Drug Approval Details
